OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Vortioxetine’s Therapeutic Potential: Cardiac Responses to Chronic Unpredictable Mild Stress in a Rat Model
Özlem Özmen, Şerife Taşan, Güli̇n Özdamar Ünal
Arquivos Brasileiros de Cardiologia (2025) Vol. 122, Iss. 2
Open Access | Times Cited: 2

Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury
V. V. Ryabov, Л. Н. Маслов, Evgeniy V. Vyshlov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 897-897
Open Access | Times Cited: 12

The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update
Roberto Campagna, Laura Mazzanti, Veronica Pompei, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1469-1469
Open Access | Times Cited: 11

NF-κB-Specific Suppression in Cardiomyocytes Unveils Aging-Associated Responses in Cardiac Tissue
Letícia Aparecida Lopes Morgado, Larissa Maria Zacarias Rodrigues, Dany Silva, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 1

The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities
Maria Moneva-Sakelarieva, Yozlem Kobakova, Spiro Konstantinov, et al.
Pharmacia (2025) Vol. 72, pp. 1-13
Open Access | Times Cited: 1

Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications
Ludmila Müller, Svetlana Di Benedetto
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8

Social Determinants of Health in Cardio-Oncology
Foster Osei Baah, Sonal Sharda, Kimberly Davidow, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 3, pp. 331-346
Open Access | Times Cited: 7

Impact of the environmental pollution on cardiovascular diseases: From epidemiological to molecular evidence
Manuel Scimeca, Valeria Palumbo, Erica Giacobbi, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38047-e38047
Open Access | Times Cited: 7

Reactive Carbonyl Species and Protein Lipoxidation in Atherogenesis
Anne Nègre‐Salvayre, Robert Salvayre
Antioxidants (2024) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 5

The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial
Kimia Motlagh Asghari, Parviz Saleh, Yaghoub Salekzamani, et al.
Nutrition and Diabetes (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Cardiometabolic implications of adipose tissue aging
Bulbul Ahmed, Melissa G. Farb, Noyan Gokce
Obesity Reviews (2024) Vol. 25, Iss. 11
Open Access | Times Cited: 4

Potential of SIRT6 modulators in targeting molecular pathways involved in cardiovascular diseases and their treatment-A comprehensive review
Raushanara Akter, Noor Fatima, Hasan Shahriyer Tonmoy, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116787-116787
Closed Access

Potencial Terapêutico da Vortioxetina: Respostas Cardíacas ao Estresse Crônico Moderado Imprevisível em um Modelo de Rato
Özlem Özmen, Şerife Taşan, Güli̇n Özdamar Ünal
Arquivos Brasileiros de Cardiologia (2025) Vol. 122, Iss. 2
Open Access

Sex Differences in Circulating Inflammatory, Immune, and Tissue Growth Markers Associated with Fabry Disease-Related Cardiomyopathy
Margarita M. Ivanova, Julia Dao, Andrew Friedman, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 322-322
Open Access

Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access

The structure of a NEMO construct engineered for screening reveals novel determinants of inhibition
Amy E. Kennedy, Adam H. Barczewski, Christina R. Arnoldy, et al.
Structure (2025)
Open Access

Integrative network pharmacology and in vitro antimicrobial assessment of Cryptomeria japonica essential oil from North-western Himalaya
Ritesh Sharma, Kapil Dev, Sanjeev Sharma, et al.
Journal of Biologically Active Products from Nature (2025) Vol. 15, Iss. 2, pp. 138-155
Closed Access

Investigating the NF-κB Signaling Pathway in Heart Failure: Exploring Potential Therapeutic Approaches
Mohsen Ghiasi
Heliyon (2024) Vol. 10, Iss. 23, pp. e40812-e40812
Open Access | Times Cited: 2

Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5

Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety
Hung-Jin Huang, Chu‐Lin Chou, Sandar Tin Tin, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1581-1581
Open Access | Times Cited: 4

Echocardiographic Assessment of Epicardial Adipose Tissue Thickness as Independent Predictor in Coronary Artery Disease
Laurențiu Brăescu, Adrian Sturza, Raluca Şoşdean, et al.
Canadian Journal of Physiology and Pharmacology (2024)
Closed Access | Times Cited: 1

Nuclear Factor Kappa B p65: A Possible Biomarker for Persistent Inflammation in HIV-1 Infection?
Sivasubramaniyan Gnanaskandan, Padma Srikanth
Cureus (2024)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top